San Clemente, Calif.-based Glaukos Corp. said Jonathan Silverstein plans to resign as a director, effective March 14.
Silverstein has been a director of Glaukos since 2008 and his term will expire at the annual shareholder meeting in 2020.
Glaukos director to resign
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
San Clemente, Calif.-based Glaukos Corp. said Jonathan Silverstein plans to resign as a director, effective March 14.
Silverstein has been a director of Glaukos since 2008 and his term will expire at the annual shareholder meeting in 2020.